Absolute Return Capital’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-95,698
Closed -$6.04M 448
2015
Q3
$6.04M Sell
95,698
-99,861
-51% -$7.13M 0.39% 88
2015
Q2
$14.3M Sell
195,559
-19,481
-9% -$1.41M 0.57% 49
2015
Q1
$14.1M Buy
215,040
+161,431
+301% +$10.7M 0.37% 87
2014
Q4
$3.49M Buy
+53,609
New +$3.45M 0.07% 272
2014
Q2
Sell
-263,378
Closed -$17.2M 1501
2014
Q1
$17.2M Sell
263,378
-260,907
-50% -$17M 0.25% 127
2013
Q4
$32.5M Buy
524,285
+54,799
+12% +$3.17M 0.36% 84
2013
Q3
$25.2M Sell
469,486
-311,719
-40% -$16.1M 0.35% 92
2013
Q2
$35.6M Buy
+781,205
New +$33.9M 0.46% 55

Other funds holding STJ

Absolute Return Capital's STJ Position: Q4 2015 in Review

Absolute Return Capital sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 95,698 shares — an estimated $6.04M sold.

Absolute Return Capital first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $35.6M in Q2 2013. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Absolute Return Capital reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Absolute Return Capital sold 95,698 St Jude Medical shares in Q4 2015, an estimated $6.04M.
  • Absolute Return Capital first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
  • Absolute Return Capital's St Jude Medical position peaked at $35.6M in Q2 2013.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Absolute Return Capital's 13F filing for Q4 2015.